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Of all the invitations one has ever been privileged to receive, I wish you 
to know that the arrival of your own was a special honour, and a special 
delight to accept—giving me, among other things, the opportunity to re-visit 
the house of our ancient Society, and to recall a t close hand many happy 
occasions within these walls some thirty years ago. It was the time of the 
great Sir Alfred Ewing as Vice-Chancellor, and, in the Medical School, of 
Sir John Fraser and Sir David W ilkie of glorious memory, whose portraits 
adorn your walls. We generated then, as doubtless you generate now, 
abiding affection for Edinburgh and its University, and not only affection 
but I confess it, sentiment, for our Royal M edical Society. Reading the 
leading article in the second num ber of Res Medica, I have been greatly 
struck by its closing sentences: “A t a time when religions, cultures and 
individuals are menaced by nuclear weapons and foreign ideologies, living 
traditions assume an im portance never envisaged by their inaugurators. Let 
us then foster unity and friendship and be worthy heirs of our heritage.” 
This is the ever-renewing and ever more significant function of the Royal 
Medical Society, and I esteem the great honour of inaugurating your two 
hundred and twenty-second Session. I mention these things to show how 
it is and why, that I received your invitation with such pleasure and gratitude.
I have taken as my subject the history and the prospects of cancer 
research. I t could be regarded as a m orbid one, but I hope to show that 
this is not necessarily so; on the contrary, that the history of the field is 
rom antic and inspiring, tha t its present state is active and exciting, and that 
its future—although by far the greater part remains to do—is full of hope 
and promise.
Cancer research can be regarded from two aspects— the purely medical, 
as a great endeavour directed to the solution of a hum an problem; and 
scientifically, from  the unique character of the disease, as an integral part 
of m odern biology. I t is unique since its basis lies in a perm anent accession 
in the growth of cells. Its history has largely been coterminous with that 
of the microscope, perm itting the development of the cell theory, which 
has been described as one of the greatest conceptions of the human mind, 
and which, although it had many precursors, was finally established as 
recently as the early part of the nineteenth century.
It is often said that the cancer cell has acquired the power of unlimited 
growth. This is strictly not so, since most normal cells are equally capable 
of unlimited growth in appropriate conditions. M ore and more certainly, 
cancer appears rather as due to the release or unmasking of that growth 
potential which cells all along possess, although exquisitely restrained. 
The mechanics of cell division appear devised to effect an equal distribution. 
Yet soon in development is superposed the mysterious feature of differentia­
tion, while the rate of growth declines. Even in the adult, however, cell
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division continues, either tem porarily as in the healing of wounds, or con­
tinuously as in the tissues of the bone marrow, intestine and skin. The 
main feature here is a matchless orderliness and precision. In the words of 
D r Isaac W atts in one of his hymns, “Strange that a harp of a thousand 
strings, should keep in tune so long.” Sooner or later, however, a single 
cell may become transform ed to a cancer cell, with altered growth properties 
which are now and henceforth no longer subservient to the needs of the 
body, but independent and frequently autonom ous. The liability to this 
change appears inherent in all cells capable of growth. It is not surprising, 
therefore, that we should find evidence of it throughout the whole of the 
plant and animal kingdom, not only in historic but also in pre-historic times.
So far we have spoken of the nature of cancer. W hat of its cause or 
causes? M odern cancer research largely dates from the time of Rudolf 
Virchow, whose D i e  C e l l u l a r  p a t h o l o g i e  was published alm ost exactly one 
hundred years ago. Rem embered for his dictum o m n i s  ce l lu la e ce l lu la ,  
he applied the cell theory to pathology, and inaugurated several decades of 
investigation of the microscopical structure of cancer in man and animals, 
carried out first in the great schools of Germany and then the world over. 
A lthough historically necessary and im portant, this was not, however, 
sufficient. Tow ards the close of the century a need became ever clearer, 
namely, for the use of the experimental method. In this country, the new 
outlook led in 1902 to the establishment of the Im perial Cancer Research 
Fund, and in 1909 to that of the Research Institute of the Cancer Hospital 
in London. The first director of the form er institution was E. F . Bashford, 
who with great genius and foresight, and with the support of a small but 
brilliant staff, was able within a brief ten years to lay the main foundations 
o f the whole subject, and to forecast its likely development and requirements 
for many further years ahead. All this helped to prom pt, or was accom ­
panied by, similar developments in the United States, in Europe, and in 
Japan.
A lthough purely medical methods alone were to prove insufficient, it 
should be noted that the first and vital clues arose from observations made 
in the; field of occupational and industrial medicine. Tow ards the end of 
the eighteenth century, Sir Percivall Pott had described the special liability 
of chimney sweeps to cancer of the scrotum, and had traced the cause 
to contam ination of the skin with soot. With the industrial revolution 
came many m ore examples, mainly due to occupational exposure to 
m ineral oil and tar. A notable case was the so-called “paraffin cancer” 
in the Scottish shalefield, described by the celebrated Joseph Bell, of whose 
association with the Royal Medical Society we are justly proud. Experim ental 
proof that m ineral oil, coal tar and pitch do in fact induce skin cancer had, 
however, to be long deferred, indeed until 1915, when Yam agiwa first pro­
duced cancer artificially through chemical means, by applying coal tar to 
the skin of the rabbit ear. Coal tar being a complex mixture of a great 
host of chemical individuals, the search then began for the responsible agent 
o r carcinogen. In the early ’twenties, Bloch in Zurich adduced evidence 
that the agent might be a complex hydrocarbon, that is, a compound con­
taining hydrogen and carbon only— and virtual proof of this was later 
obtained by my own predecessor, Sir Ernest Kennaway, at the Cancer 
Hospital. Through his work and that of his school, the picture gradually 
emerged of carcinogenic substances built through the conjugation of benzene 
rings.
Early in these investigations, it was repeatedly noted that cancer-producing 
tars exhibited the property of fluorescence in ultraviolet light, that is, to 
absorb invisible light of short wave-length, and to emit visible light of longer 
wave-length. In 1927, W. V. M ayneord, again at the Cancer Hospital, took
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the m atter decisively forward when he indicated that the fluorescence spectra 
of such tars showed qualities which appeared to be characteristic. This 
spectrum of cancer-producing tar proved to be, in Kennaw ay’s words, "the 
single thread that led all through this labyrinth,” and it soon enabled him, 
and his colleagues, to track down the carcinogenic agent. Since it was already 
suspected to be a complex hydrocarbon, the next step was to examine the 
spectra of those polycyclic hydrocarbons already known in pure form, and 
constituted from the fusion of various numbers of benzene rings. Very shortly, 
H ieger was able to m ake the key discovery that 1 : 2-benzanthrace  
(comprising four such rings), also possessed the characteristic spectrum. By 
a curious accident, C lar in 1929 had just described the synthesis of the 
related hydrocarbon containing five fused rings, {1 : 2 :5 : 6-dibenzanthru-  
cene), and in the same year Kennaway and Hieger proved this substance 
to be carcinogenic in mice—the first pure chemical individual to be recog­
nised as possessing this property. The fluorescent spectrum was also used 
to great purpose in the isolation of the naturally-occurring carcinogenic agent 
from  pitch. This proved to be another pentacyclic arom atic hydrocarbon, 
namely 3 : 4-benzpy rene,  which Cook and Hewett were soon (in 1933) to 
prove by synthesis. In the same year, Cook and Haslewood produced 
m e t h y l c holanthrene  from  a bile-acid, so raising the whole question—still 
undecided—whether traces of highly potent carcinogens can be formed 
in v ivo  from perturbations of the normal m etabolism of steroids. A  chief 
result of all this work was eventually to provide an amazingly satisfying and 
complete picture of the relationship existing, within this series, between 
chemical constitution and biological action.
In the intervening years, many older chemical classes had been uncovered, 
in no way related to the cyclic hydrocarbons, bu t equally endowed with 
carcinogenic qualities—various arom atic amines, especially those involved 
in the causation of cancer of the bladder; a host of azo dyestuffs with the 
special propensity to evoke tum ours of the liver; a series of aminostilbenes 
with very diversified carcinogenic properties; and many others. To these 
we m ust add a great range of purely physical agents, including ultraviolet 
radiation itself, X-rays, radium  and thorium , and a host of radio-isotopes 
arising from the atom ic energy program m e, especially radiophosphorous, 
radioiodine and radiostrontium . Of late we have also recognised the 
carginogenicity of many macromolecules and plastics, and the special function 
in carcinogenesis which may be played by the metals, as also the role of 
many biological agents, e.g. those viruses responsible for the induction and 
propagation of certain tum ours in anim als (although not so far in man)— 
topics any one of which could easily exhaust a whole lecture in itself.
In none of these cases have we precise knowledge of the mode of action, 
or of the site a t which it is excited within the cell. Only in the past few 
years have there come certain hints, through the discovery of carcinogenicity 
in yet another chemical class, namely the nitrogen m ustards—substances 
developed in the Second W ar for the purpose of chemical warfare, and 
nitrogen analogues of that sulphur m ustard or “ m ustard gas” which had 
been used in the W ar of 1914-18. The nitrogen m ustards have the advantage 
of relative chemical simplicity, with features which are suggestive, or even 
indicative, of possible modes of action. The action upon dividing cells is 
highly direct, leading to cytological abnorm alities indistinguishable from 
many which can equally be produced by ionising radiation. On this account 
they are not unreasonably described as radiom im etic, and it is certainly 
rem arkable that just as X-radiation is employed in the treatm ent of cancer, 
so also can some of the m ustards, in the palliation of certain forms at least. 
Contrariwise, just as X-rays can be cancer-producing, so also can the
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m ustards. In m any cases th e tum ou rs so p ro d u c ed  b ea r signs— as a kind 
of im p rin t— th a t th e  action  has involved the  nuclei and  chrom osom es. A  
certain  ex ten t of chem ical reactivity  is re q u ired , suggesting ag ain  th a t the 
bio logical en d -resu lt m ay depen d  upon reaction  w ith som e cellu lar co m ­
p o n en t so fa r undefined. T h e  m ain  features of the nitrogen  m u stard s is their 
possession of tw o o r m ore h alo alk y l side-chains. W ithin th e  series this indeed 
ap p ears to be a req u irem en t for biological activ ity , an d  led to the p rop o sal 
th a t activity  m ight in fact d epend upon chem ical cross-linkage, as fo r exam ple 
betw een the contiguous linear m acrom olecules of the chrom osom es th em ­
selves. A lth o u g h  this hypothesis is now  know n to  be unduly  sim ple, it proved 
trem endously  fru itfu l in developm ent, leading  for ex am p le to  th e  ap p lica tio n  
of m uch know ledge a lread y  av a ilab le  in the field of cross-linking agents 
in textile  technology, and  hence to  the ra p id  discovery of o th er series with 
s im ilar biological effects— epoxides, polyethylene im ines and  dim esyl co m ­
p o u n d s— now  classed u n d er the general heading  of b io logical a lkylating  
agents.
T h e  exact n a tu re  of the b io logical recep to r is still not know n. It is very 
p ro b a b ly  genetical in fu nctio n , as reaction  w ithin the nucleus an d  upon the 
chrom osom es m ight infer. H ow ever, such  reaction  w ould certain ly  in troduce 
w idespread  repercussions in the cytoplasm , an d  d irect action by certain  
carcinogens u po n  the organelles of the cytoplasm  is by no m eans excluded. 
N otw ithstand ing , a p ro m in en t ca n d id a te  fo r the seat of action of th e carc in o ­
genic a lk y latin g  agents is w ith o ut d o u b t— an d fo r m any reasons altho ug h  
n one is as y et decisive— th e deo xy rib on ucleic acid  of the chrom o som e stru c­
ture, as the  chem ical basis of cell genetics an d  heredity . A  g reat im petus has 
been given to  these studies by the p rop osals fo r nucleic acid  stru ctu re  put 
fo rw ard  by C rick  and W atson— of the b o n d in g  of pyrim idine an d  purine 
base p airs to yield essentially  su p erp o sab le  stru ctu res, and  of the co m p le­
m en tary  d isposition  of these as bridges in a d o u b le  helix of p h o sp h ate-su g ar 
chains; an d  we already have som e precise chem ical in form ation  as to  the 
actio n  u pon such a stru ctu re  b o th  of ionising ra d ia tio n s and  of the ions 
y ielded by a lky latin g  agents. B ut fu rth e r ad v an ce m ust largely depend  upon 
o u r d eep er know ledge of ch ro m o som e stru ctu re . W hile w aiting, we can gain 
m uch th ro u g h  the use of w h at is still the m ost fav o u rab le  m ateria l— nam ely 
the g iant chrom osom es of the salivary  gland  of the fru it fly D r o s o p h i l a —  
in studies of th e  chem ical basis of biological m u tatio n  generally , of w hich 
carcinogenesis m ay be a special case. A ctin g  upon such m ateria l, the 
a lk y lating  agents frequ ently  p ro d u ce  changes of the n a tu re  o f deletion , and 
this, w ith o th e r con sideratio ns, has led to  th e view th a t can cer cau satio n  could 
be d u e  to  co m b in atio n  of the agent w ith  nucleic acid, so leading  to  defects 
in its synthesis o r stru ctu re . T his process w ould  in terru p t the essential p re ­
cision of th e  nucleic acid , and  p revent th e fo rm atio n  of certain  protein  
m olecules (a n d  especially p erh ap s g ro w th -reg u latory  enzym e-proteins vital 
to  the co n tro l of no rm al cell d iv ision ), fo r w hich we know  the integrity  of 
th e  nucleic acid  s tru ctu re  is necessary an d  responsible. In th e case of the 
carcinogenic h y d ro carb o n s an d  azo-dyestuffs, th ere  is also evidence th a t the 
sam e deletion of key p ro tein s can be b ro u g h t a b o u t by co m bin atio n  of the 
carcinogen with protein  m olecules them selves, d irectly.
W e th erefo re  a p p ro ach  the view  th a t carcinogenesis is a process of 
b io logical m u ta tio n  by loss, and  th a t th ere is no tru e  acquisition  of a new 
g row th  p ro p erty  on th e  p a r t  of th e  cancer cell, b u t ra th e r the un m askin g  
of th e gro w th  po ten tial w hich its n o rm al p recu rso r had  all along  possessed. 
T h e  general co nception  has still to  be tested , an d  could clearly  have the 
w idest im plications. T h ere  is an increasing n u m b er of diseases recognised 
as d ue to  enzym e deficiency, and  som e of them  can b e  con trolled  by re sto r­
ing th e defect th ro u g h  a k in d  of sub stitu tiv e  ch em o th erap y . It w ell m ay be.
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in the future, that cancer too will fall in this class, and become amenable 
to control through a re-imposition, from  without, of that growth regulation 
which the cancer cell itself has lost forever. A t any rate it can fairly be 
said we are at least approaching certain correlations, between the reactive 
properties of given carcinogens, the places a t which and the m ethods by 
which they combine in the cell, and the perm anent alterations in growth 
behaviour, which come about as the result. A lthough so much remains to 
do, the story is great and growing. When one day it comes finally to be 
told, it will be seen to have meaning far beyond the sphere of medicine alone, 
and to be in part a model of what can be achieved by the hum an mind 
through the interaction of biology, chemistry and physics.
I end as I began, with thanks to the Society and all its members for this 
kindly privilege, I  also wish to record special indebtedness to my colleague 
M r K. G. M orem an, and to the officers of the Society for indispensable 
assistance. M ay the Society enjoy strength and prosperity not only in the 
present new Session, but in all those which lie ahead, in a future which 
we are confident will continue that unfolding of the art, science, and achieve­
ments of M edicine, towards which the Society itself, in its long history, 
has m ade no mean contribution.
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